The Wire

Quick-hit updates from the worlds of medical marketing, including everything from clinical news to device approvals to agency expansion and consolidation.

AstraZeneca expands oncology portfolio with $320M deal for Neogene Therapeutics
AstraZeneca expands oncology portfolio with $320M deal for Neogene Therapeutics
Jack O'Brien
November 29, 2022
10:49 am

The deal is slated to be closed during Q1 2023, subject to customary closing conditions and regulatory approvals.

Study: Majority of patients see providers with access to POC media
Study: Majority of patients see providers with access to POC media
Larry Dobrow
November 23, 2022
9:43 am

The report, from the Point of Care Marketing Association and MedFuse, is designed to illustrate the increasing reach of POC marketing.

Stymied on Seagen, Merck bolts on Imago for $1.35B
Stymied on Seagen, Merck bolts on Imago for $1.35B
Jack O'Brien
November 21, 2022
10:03 am

The transaction to acquire the clinical stage biopharmaceutical company is expected to close in Q1 2023.

Fingerpaint rebrands market access consultancy 1798
Fingerpaint rebrands market access consultancy 1798
Larry Dobrow
November 15, 2022
1:03 pm

The unit, acquired by Fingerpaint in 2020, will now be known as Fingerpaint Market Access.

Insilico Medicine inks research deal with Sanofi for up to $1.2B
Insilico Medicine inks research deal with Sanofi for up to $1.2B
Jack O'Brien
November 8, 2022
1:43 pm

Sanofi will be on the hook for additional payments if certain research, development and sales milestones are met by Insilico.

Alkermes plans to spin off oncology unit
Alkermes plans to spin off oncology unit
Jack O'Brien
November 2, 2022
12:42 pm

The separation is expected to be completed in the second half of 2023.

Citeline, Norstella complete $5B merger
Citeline, Norstella complete $5B merger
Jack O'Brien
November 1, 2022
11:14 am

Citeline will join four other brands, Evaluate, MMIT, Panalgo and The Dedham Group, as part of Norstella.

Thermo Fisher Scientific buys European diagnostics firm for $2.6B
Thermo Fisher Scientific buys European diagnostics firm for $2.6B
Jack O'Brien
October 31, 2022
10:06 am

The company is acquiring The Binding Site Group from private equity firm Nordic Capital.

Amgen closes ChemoCentryx deal for $3.7B
Amgen closes ChemoCentryx deal for $3.7B
Jack O'Brien
October 20, 2022
11:28 am

The transaction was first announced in August.

AbbVie buys DJS Antibodies for $255M, expands immunology portfolio
AbbVie buys DJS Antibodies for $255M, expands immunology portfolio
Jack O'Brien
October 20, 2022
11:02 am

The pharma company adds DJS-002, DJS’ lead product candidate, to its arsenal.

  • From Our Partners